New roadmap links liver cancer biology to immunotherapy and precision medicine
Cătălin Roșioru
The Mount Sinai Hospital / Mount Sinai School of Medicine Apr 17 2026 A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the deadliest cancers worldwide. Published in Cell , the study, "Hallmarks of Liver Cancer: Therapeutic Implications" (10.1016/j.cell.2026.03.001), applies the widely used "Hallmarks of Cancer" framework to liver tumors, linking the
din zilele anterioare